Boyce Michael, Bryant Kevin F, Jousse Céline, Long Kai, Harding Heather P, Scheuner Donalyn, Kaufman Randal J, Ma Dawei, Coen Donald M, Ron David, Yuan Junying
Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Science. 2005 Feb 11;307(5711):935-9. doi: 10.1126/science.1101902.
Most protein phosphatases have little intrinsic substrate specificity, making selective pharmacological inhibition of specific dephosphorylation reactions a challenging problem. In a screen for small molecules that protect cells from endoplasmic reticulum (ER) stress, we identified salubrinal, a selective inhibitor of cellular complexes that dephosphorylate eukaryotic translation initiation factor 2 subunit alpha (eIF2alpha). Salubrinal also blocks eIF2alpha dephosphorylation mediated by a herpes simplex virus protein and inhibits viral replication. These results suggest that selective chemical inhibitors of eIF2alpha dephosphorylation may be useful in diseases involving ER stress or viral infection. More broadly, salubrinal demonstrates the feasibility of selective pharmacological targeting of cellular dephosphorylation events.
大多数蛋白质磷酸酶本身几乎没有底物特异性,这使得对特定去磷酸化反应进行选择性药理抑制成为一个具有挑战性的问题。在一项针对保护细胞免受内质网(ER)应激的小分子筛选中,我们鉴定出了salubrinal,它是一种细胞复合物的选择性抑制剂,该复合物可使真核翻译起始因子2α亚基(eIF2α)去磷酸化。Salubrinal还可阻断由单纯疱疹病毒蛋白介导的eIF2α去磷酸化,并抑制病毒复制。这些结果表明,eIF2α去磷酸化的选择性化学抑制剂可能对涉及内质网应激或病毒感染的疾病有用。更广泛地说,salubrinal证明了对细胞去磷酸化事件进行选择性药理靶向的可行性。